Research Across Sectors to Give Impetus to Global DNA Sequencing Market

Pune, India, 2022 /press release/- Market Research Future Published a Upcomming Report on DNA Sequencing Market Research Report.

Market Overview:

The DNA Sequencing Market Size will rake USD 4.8 billion in revenues while expanding with an 11.20% CAGR in the 2023-2030. It includes drivers that are going to cement DNA sequencing’s market for the forthcoming years. The technology has been adopted to achieve precision in medicine, and its rising incorporation in associated projects in the human genome, genetics for livestock and agriculture research can take the market ahead. Now the demand for next-generation sequencing (NGS) is acting like a stimulus.

On the flip side, the market can experience some leashing from expensive machinery, complex algorithms, the dearth of expertise and ethical questions. But its multifarious effects can give back the market the much-needed thrust.

Industry News:

Garvan Institute of Medical Research recently published an article that shows how genomics is considerably bringing down the price of DNA sequencing. Earlier DNA sequencing used to cost millions now it costs only a few thousand. This revolutionary changes in technology have brought medicine on the cusp of a major transformation with personalized drugs waiting at the entry line. 

National Human Genome Research Institute has announced a grant program to support scientists engaged in the field of genomics and DNA sequencing. Illumina, a specialist in manufacturing DNA sequencing equipment, has helped in the foundation of Helix which lets individuals have their DNA sequencing ready for a meager price, and the individual can choose what type of information he or she would like to have from their DNA App store later. Mayo Clinic and Geisinger health system are also partnering in this with Helix.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of DNA Sequencing Market Research Report

Segmentation:  

The global DNA sequencing market can be segmented by devices, process, technology, applications, and end users.

Based on the types, the market can be segmented into instruments, consumables, and others. Instruments can be sub-segmented into sequencers, bioreactors, and others. Consumables is sub-segmented into reagents and chemicals, laboratory wares, and other.

Process-wise the market includes sample preparation, sequencing, data analysis, and others.

Technology-based segmentation comprises chain terminator DNA sequencing, next-generation DNA sequencing, and others.

Application-wise segmentation includes diagnostics, drug discovery, precision medicine, livestock research, agriculture research, and others.

Based on technique, the market consists ion semiconductor sequencing, pyro-sequencing, synthesis sequencing (SBS), ligation sequencing, single molecule real-time sequencing (SMRT), chain termination sequencing, nanopore sequencing, and others.

Based on the end-users, the market includes hospitals and clinics, forensics, genomics and livestock’s, academics and research institutes, pharmaceutical and biotechnology industry, and others.

Regional Analysis:

Based on the regions, the market can be segmented as North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and Rest-of-the-World (RoW).

North America accounts for the maximum market share with the U.S. spearheading the region with ease. The region has a superior infrastructure which is boosting the researches substantially, and the tendency to adopt new technologies is contributing significantly to the market growth. The presence of several market influencers such as Thermo Scientific, Perkin Elmer, and others are also helping the region. Europe’s market is banking on its robust infrastructure and increasing healthcare expenditure. Furthermore, governments of this region are supporting researches with great enthusiasm, and private investors are engaging themselves in taking the market further ahead. The APAC market is expected to have a remarkable growth during this period with China, South Korea, Japan, and India fetching in much revenue.

Competitive Landscape:

The competitive market is witnessing several strategies such as mergers and collaborations that could take the market forward. For instance, Illumina bought Edico Genome, a data analysis company that provides solutions for NGS. Myriad Genetics acquired Counsyl, a specialist in carrier screening and non-invasive prenatal screening.

Prominent players profiled in the report are Siemens AG, Oxford Nanopore technologies, Roche Holdings AG, Agilent Technologies Inc., Genia Corporation, Illumina, Perkin Elmer Koninklijke Philips N.V., Pacific Biosciences, Life Technologies, Johnson & Johnson, Deep Genomics, Inc., Illumina, Eppendorf, Tecan, and Thermo Scientific, General Electric Company, Hamilton Thorne Biosciences, Siemens Healthineers GmbH, Myriad Genetics, Bayer Corporation, Beckman Coulter and others